Physician profile
Stanley Parman
NPI 1306816152
$2,301.86
in general payments reported to CMS, 2019-2025
20 companies · $39.98 in 2025
The $39.98 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $939 · 2020: $384 · 2021: $482 · 2022: $149 · 2023: $248 · 2024: $60.29 · 2025: $39.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $758.00 | 2019 | |
| Novo Nordisk INC | $693.26 | 2019-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $147.67 | 2020-2022 | |
| Abbott Laboratories | $135.88 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $122.99 | 2019-2021 | |
| Amgen INC. | $74.00 | 2021-2023 | Repatha, Otezla |
| Pfizer INC. | $68.80 | 2021-2023 | |
| Genentech USA, INC. | $57.41 | 2019-2021 | |
| Glaxosmithkline, LLC. | $48.83 | 2020-2023 | Arexvy |
| Exact Sciences Corporation | $42.47 | 2023 | Cologuard Collection Kit |
| Bioventus LLC | $23.11 | 2021 | |
| Amarin Pharma, INC. | $18.21 | 2020 | |
| Abbvie INC. | $15.38 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.38 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.00 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $14.22 | 2024 | |
| Vbi Vaccine (Delaware) INC. | $14.16 | 2022 | |
| Idorsia Pharmaceuticals US INC | $13.55 | 2023 | Quviviq |
| Eisai INC. | $11.94 | 2019 | |
| Paratek Pharmaceuticals, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Parman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.